598
Participants
Start Date
March 31, 2002
Primary Completion Date
October 31, 2002
Study Completion Date
October 31, 2002
insulin detemir
Individually adjusted dose administered subcutaneously (s.c., under the skin) twice daily
insulin aspart
Individually adjusted dose administered subcutaneously (s.c., under the skin) prior to meals
insulin NPH
Individually adjusted dose administered subcutaneously (s.c., under the skin) twice daily
human soluble insulin
Individually adjusted dose administered subcutaneously (s.c., under the skin) prior to meals
Novo Nordisk Investigational Site, Skopje
Novo Nordisk Investigational Site, Gjettum
Novo Nordisk Investigational Site, Kongsvinger
Novo Nordisk Investigational Site, Copenhagen
Novo Nordisk Investigational Site, Hillerød
Novo Nordisk Investigational Site, Slagelse
Novo Nordisk Investigational Site, Holbæk
Novo Nordisk Investigational Site, Køge
Novo Nordisk Investigational Site, Kristiansand
Novo Nordisk Investigational Site, Arendal
Novo Nordisk Investigational Site, Rådal
Novo Nordisk Investigational Site, Svendborg
Novo Nordisk Investigational Site, Århus C
Novo Nordisk Investigational Site, Silkeborg
Novo Nordisk Investigational Site, Hjørring
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Torino
Novo Nordisk Investigational Site, Narbonne
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Asti
Novo Nordisk Investigational Site, Genova
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Bergamo
Novo Nordisk Investigational Site, Plzen - Lochotin
Novo Nordisk Investigational Site, Montpellier
Novo Nordisk Investigational Site, Padua
Novo Nordisk Investigational Site, Grenoble
Novo Nordisk Investigational Site, Liberec
Novo Nordisk Investigational Site, Ravenna
Novo Nordisk Investigational Site, Hradec Králové
Novo Nordisk Investigational Site, Lucca
Novo Nordisk Investigational Site, Lorient
Novo Nordisk Investigational Site, Lille
Novo Nordisk Investigational Site, Prato
Novo Nordisk Investigational Site, Kokkola
Novo Nordisk Investigational Site, Bari
Novo Nordisk Investigational Site, Kuopio
Novo Nordisk Investigational Site, Viljandi
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Pärnu
Novo Nordisk Investigational Site, Poitiers
Novo Nordisk Investigational Site, Kemi
Novo Nordisk Investigational Site, Catania
Novo Nordisk Investigational Site, Catania
Novo Nordisk Investigational Site, Rovaniemi
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Timișoara
Novo Nordisk Investigational Site, Junín
Novo Nordisk Investigational Site, Morón
Novo Nordisk Investigational Site, Angers
Novo Nordisk Investigational Site, Alessandria
Novo Nordisk Investigational Site, Varaždin
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Mougins
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Gjøvik
Novo Nordisk Investigational Site, Kongsberg
Novo Nordisk Investigational Site, Bydgoszcz
Novo Nordisk Investigational Site, Bydgoszcz
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Krakow
Novo Nordisk Investigational Site, Lodz
Novo Nordisk Investigational Site, Lublin
Novo Nordisk Investigational Site, Szczecin
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Moldava nad Bodvou
Novo Nordisk Investigational Site, Falun
Lead Sponsor
Novo Nordisk A/S
INDUSTRY